Spinal Muscular Atrophy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Genetic Newborn Screening for Cystinosis and Spinal Muscular Atrophy
Conditions: Cystinosis; Cystinosis, Nephropathic; Spinal Muscular Atrophy Intervention: Diagnostic Test: molecular-based screening Sponsors: Cystinose Stiftung; Labor Becker & Kollegen, Munich, Germany; Screening Labor Hannover; Genetikum, Ulm, Germany; Bavarian State Office of Health and Food Safety (LGL), Unterschleißheim, Germany; Internal Medicine, Freiburg University Hospital, Freiburg, Germany; Attorney DSZ Rechtsanwälte GmbH, Barkhovenallee 1, 45239 Essen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials
A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma
Condition: Spinal Muscular Atrophies Intervention: Other: Onasemnogene Abeparvovec Sponsor: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials
